Item 1.01. Entry into a Material Agreement.
On
company (“Weber-Stephen”), a subsidiary of
entered into an amendment (the “Amendment”) to that certain Credit Agreement
dated as of
pursuant to the Amendment, the “Credit Agreement”) by and among Weber-Stephen,
as borrower,
party thereto and
and as administrative agent (the “Administrative Agent”).
Pursuant to the Amendment, the maximum net first lien leverage ratio covenant of
7.00:1.00 (the “Financial Covenant”) is waived for the fiscal quarters ending
below (the “Waiver”).
The Waiver shall be automatically terminated upon the occurrence of any Covenant
Waiver Termination Event (as defined in the Credit Agreement to include, among
other events, if the Take-Private Transaction (as defined in the Credit
Agreement) does not occur within a certain period). If the Waiver is terminated,
Weber-Stephen must test the Financial Covenant for the most recently ended
fiscal quarter (the “Testing Quarter”) for which financial statements have been
delivered to the Administrative Agent, subject to its right to exercise an
equity cure as set forth in the Credit Agreement.
If the Waiver is terminated and Weber-Stephen is not in compliance with the
Financial Covenant for the
remedies of the Revolving Facility Lenders (as defined in the Credit Agreement)
provided for under the Credit Agreement, Weber-Stephen must pay the Revolving
Facility Lenders a fee (the “Contingent Fee”) in an amount equal to 3.0% per
annum in respect of any outstanding loans under the Revolving Facility (as
defined in the Credit Agreement). The Contingent Fee will continue to be payable
until Weber-Stephen is in compliance with the Financial Covenant for any two
consecutive fiscal quarter period ending on or after
which time the Contingent Fee will terminate permanently.
From and after the earlier of (a)
Specified Equity Contribution (as defined in the Credit Agreement) is made,
Weber-Stephen may not incur any further borrowings under the Revolving Facility
if after giving effect to any such borrowing, the obligations outstanding under
the Revolving Facility would exceed (x)
Loan Agreement Cure (as defined in the Credit Agreement) has occurred,
million
terminate upon the earlier of (x) one year following the consummation of the
Take-Private Transaction and (y) the date on which Weber-Stephen demonstrates
compliance with the Financial Covenant for any fiscal quarter ending on or after
Each lender under the Revolving Facility that consents to the Amendment will
receive an amendment fee in an amount equal to 0.25% of the Revolving Facility
Commitments (as defined in the Credit Agreement) held by such lender as of the
date of the Amendment.
The foregoing description of the Amendment is a summary and is qualified in its
entirety by reference to the Amendment, a copy of which is filed as Exhibit 10.1
to this Form 8-K and incorporated herein by reference.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant.
The information set forth in Item 1.01 above is incorporated herein by
reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 10.1 Fourth Amendment to Credit Agreement dated as ofDecember 27, 2022 by and amongWeber-Stephen Products LLC , as the Borrower,Weber-Stephen Products Belgium BV , as the Euro Borrower,Bank of America, N.A ., as Administrative Agent and the Lenders party thereto. 104 Cover Page Interactive Data File, formatted in Inline XBRL
© Edgar Online, source